Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

NK cells

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 7, 2026 · PHASE 1 TRIAL

Natural Killer Cells and Bortezomib to Treat Cancer

ClinicalTrials.gov

Phase 1 dose-escalation study with no results posted; establishes safety and feasibility of combined NK cell and bortezomib therapy in treatment-refractory cancers, but is early-stage and uncontrolled.

PreliminaryBortezomib NCT00720785 Chronic Myeloid Leukemia (CML)

Reported

Planned enrollment35

PhasePhase 1

Primary outcomeSafety of escalating NK cell doses of adopt…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support